Screener / SEC EDGAR /CIK 0001807794 /10-K filed Jun 15, 2026, compared with Jul 2, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Semiconductors

Credo Technology Group Holding Ltd CRDO

Compare with peers Embed
SEC comment letters, last 20 years

2 reviews of CRDO's filings by SEC staff

UPLOAD and CORRESP
Reviews 2 latest letter Feb 15, 2023
Questions asked 39 each answered in the company's own letter
No closing letter 1 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 8 UPLOAD
  2. 2. Questions in them 39 numbered comments
  3. 3. Company replies 4 CORRESP
  4. 4. Reviews closed 1 of 2 closing letter

Half the closed reviews took 50 days or less from the first letter to the closing letter.

Form 10-K for the Fiscal Year Ended April 30, 2022

2023-02-15 to 2023-04-06 · 5 questions · 2 letters from the SEC, 2 from the company
Review closed 2023-04-06
RevenueResults discussion (MD&A)Liquidity and cashNon-GAAP measures
Management's Discussion and Analysis of Financial Condition and Results of Operations · Results of Operations, page 78
SEC asked (1)
Where you describe two or more business reasons that contributed to a material change in a financial statement line item between periods, please quantify, where possible, the extent to which each change contributed to the overall change in that line item. In addition, where you identify intermediate causes of changes in your operating results, also describe the reasons underlying the intermediate causes.
Rest of the question

As an example, you disclose on page 79 that revenues increased in fiscal 2022 due to an increase in IC units sold and revenues relating to AEC cables that were introduced in fiscal 2021. Please quantify the extent to which the overall change is attributable to each identified factor and explain in reasonable detail the reasons driving fluctuations in each factor. Refer to Item 303(a) of Regulation S-K and SEC Release No. 33-8350.

CRDO answered
The Company acknowledges the Staff’s comment and, commencing with the Form 10-Q for the fiscal quarter ended January 28, 2023, and in all future periodic reports on Form 10-Q and Form 10-K, will quantify where possible each material factor that contributed to the overall change in line items where two or more factors contributed to a material change in a financial statement line item between periods including offsetting factors. In addition, we will identify intermediate causes of changes in our operating results, and also describe the reasons underlying the intermediate causes.
Read in the reply
In its next report

First report after the company's reply of Mar 7, 2023: 10-K filed Jun 23, 2023 ↗, against the 10-K filed Jun 8, 2022 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Liquidity and Capital Resources, page 80
SEC asked (2)
Please provide a more informative analysis and discussion of changes in cash flows, including changes in working capital components, for each period presented. In doing so, explain the underlying reasons and implications of material changes between periods to provide investors with an understanding of trends and variability in cash flows.
Rest of the question

Ensure your discussion and analysis is not merely a recitation of changes evident from the financial statements. Refer to Item 303(a) of Regulation S-K and SEC Release No. 338350. Financial Statements Notes to Consolidated Financial Statements 2. Significant Accounting Policies

CRDO answered
The Company acknowledges the Staff’s comment and, commencing with the Form 10-Q for the fiscal quarter ended January 28, 2023, and in all future periodic reports on Form 10-Q and Form 10-K, we will include a more informative analysis and discussion of changes in our cash flow from operating activities, consistent with Item 303(a) of Regulation

S-K and SEC Release No. 33-8350.
Read in the reply
In its next report

First report after the company's reply of Mar 7, 2023: 10-K filed Jun 23, 2023 ↗, against the 10-K filed Jun 8, 2022 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Revenue Recognition , page 96
SEC asked (3)
Your disclosure on page 97 indicates that your IP License Revenue consists of perpetual licenses, support and maintenance, and royalties. While you identify when revenue is recognized for customer support and royalties, you do not disclose when revenue is recognized for perpetual licenses granted.
Rest of the question

Please identify for us and disclose, pursuant to ASC 606-10-50-12, the specific performance obligations of your IP License revenue stream and when you satisfy such performance obligations. In doing so, tell us how you applied ASC 606-10-55-54 through -65B in determining your accounting treatment. Exhibits 31.1 and 31.2, page 1

CRDO answered
The Company acknowledges the Staff’s comment and, commencing with the Form 10-Q for the fiscal quarter ended January 28, 2023, and in all future periodic reports on Form 10-Q and Form 10-K, our financial statements will include the following updated IP license revenue policy disclosure

(marked against the disclosure included in the Form 10-K).

***

IP License Revenue - The Company’s

IP license revenue consists of a perpetual licenses, support and maintenance, and royalties.
Rest of the answer

The Company enters into perpetual semiconductor IP license agreements that have a fixed fee, whereby licensees pay a fixed fee for the right to incorporate the Company’s IP technologies into the licensee’s products. The Company’s license arrangements IP license agreements do not typically grant the customer the right to terminate for convenience. and

Where such rights exist, termination is prospective, with no refund of fees already paid by the customer.

IP revenue recognition is dependent on the nature and terms of each agreement. The Company recognizes license revenue at the point of time of the delivery of the IP.

In connection with the license arrangements, the Company offers support and maintenance to assist customers in bringing up and qualifying their final product. Revenue from customer support is deferred and recognized ratably over the support period, which is typically one year.

In certain cases, the Company also charges licensees royalties related to the distribution or sale of products that use its technologies. Such royalties are reported to us on a quarterly basis. The Company estimates the sales-based royalties earned each quarter primarily based on its customers’ reporting of sales activity incurred in that quarter. The Company recognizes the estimated royalty revenue when it is probable that reversal of such amounts will not occur. Any differences between actual royalties owed by a customer and the quarterly estimates are recognized when updated information becomes available.

We believe the above policy complies with the guidance in ASC 606-10-55-54 through –65B for the following reasons:

a) The license delivered is distinct and has significant standalone functionality as the licensee can immediately, upon delivery, use our IP to perform design work to incorporate our IP into their products.

b) The functionality of our IP to which the customer has rights is not expected to substantially change subsequent to the delivery of the IP, as the customer does not have rights to modify the IP delivered.

Read in the reply
In its next report

First report after the company's reply of Mar 7, 2023: 10-K filed Jun 23, 2023 ↗, against the 10-K filed Jun 8, 2022 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Revenue Recognition , page 96
SEC asked (4)
We note that Exhibits 31.1 and 31.2 are incomplete, as they omit paragraph 4(c) of Item 601(b)(31) of Regulation S-K. Please amend your filing to include corrected certifications.
CRDO answered
The Company acknowledges the Staff’s comment and respectfully informs the Staff that the Company will file Amendment No. 1 on Form 10-K/A to its Annual

Report on Form 10-K for the fiscal year ended April 30, 2022, which amendment will include revised Exhibits 31.1 and 31.2 to include paragraph 4(c) of Item 601(b)(31) of Regulation S-K.

*****

In connection with our response to the

Staff's comments, we acknowledge that the Company and its management are responsible for the accuracy and adequacy of its disclosures, notwithstanding any review, comments, action or absence of action by the
Rest of the answer

Staff. Should you have any questions or comments with respect to the above, or believe that a call would be helpful, please do not hesitate to contact me at (415) 377-6101.

Read in the reply
In its next report

First report after the company's reply of Mar 7, 2023: 10-K filed Jun 23, 2023 ↗, against the 10-K filed Jun 8, 2022 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Notes to Unaudited Condensed Consolidated Financial Statements
SEC asked
Revenue Recognition, page 13 1. We note your disclosure on page 14 that you issued approximately 4.1 million warrants during December 2021 to your customer, Amazon.com NV Investment Holdings LLC, that "will vest in tranches over the contract term based on the amount of global payments" from the customer and its affiliates.
Rest of the question

Citing relevant authoritative accounting guidance, tell us the specific grant date(s) you will use to record the fair value of the warrants. In doing so, explain if each tranche will be valued using a different grant date and explain the reasons for your determination. Form 8-K furnished March 1, 2023 Exhibit 99.1, page 1 2. We note that you present non-GAAP gross profit, net income (loss), and diluted net income (loss) per share that exclude warrant contra revenues. Considering these amounts are directly related to revenue generating activities with customers, please remove these adjustments from all non-GAAP measures. See Question 100.04 of the Compliance and Disclosure Interpretations on Non-GAAP Financial Measures.

CRDO answered
In accordance with ASC 606-10-32-25A, the Company measured the warrants using ASC 718. In accordance with ASC 718-10-20 guidance, the grant date was determined to be December 28, 2021, which was the date that satisfied the definition of grant date based on the following factors:

a. Credo and Amazon reached a mutual understanding of key terms and conditions upon signing of the agreement on December 28, 2021;

b. On December 28, 2021, Credo became contingently obligated to issue Credo’s ordinary shares to Amazon based on purchase of goods or services as a customer;

c.
Rest of the answer

Approval by Credo’s board of directors was obtained on December 15, 2021 (prior to the signing of the agreement); and d. Amazon began to benefit from or to be adversely affected by a change in Credo’s share price once the exercise price of the warrants was set at $10.74 on December 28, 2021 (the date of the signing of the agreement).

The global payments from the customer and its affiliates meet the definition of a performance condition under ASC 718. As this performance condition only affects the vesting of the award, it is not considered in estimating the fair value of a warrant share in accordance with ASC 718-10-30-27. Therefore, all warrants were valued on the grant date, which occurred upon signing of the agreement.

Form 8-K filed March 1, 2023

Exhibit 99.1, page 1

2. We note that you present non-GAAP gross profit, net income (loss), and diluted net income (loss) per share that exclude warrant contra revenues. Considering these amounts are directly related to revenue generating activities with customers, please remove these adjustments from all non-GAAP measures. See Question 100.04 of the Compliance and Disclosure Interpretations on Non-GAAP Financial Measures.

Response: The Company acknowledges the Staff’s comment and will remove warrant contra revenue adjustments from its non-GAAP measures in future financial releases and future filings with the

Commission.

*****

In connection with our response to the Staff's comments, we acknowledge that the Company and its management are responsible for the accuracy and adequacy of its disclosures, notwithstanding any review, comments, action or absence of action by the Staff. Should you have any questions or comments with respect to the above, or believe that a call would be helpful, please do not hesitate to contact me at (415) 377-6101.

Read in the reply

Also in this review: request for more time, Feb 23, 2023, closing letter, 2023-04-06

Form S-1

2021-09-03 to 2022-01-18 · 34 questions · 6 letters from the SEC, 2 from the company
No closing letter
Risk factorsChinaLiquidity and cashResults discussion (MD&A)CybersecurityExecutive payRevenue
SEC letter of Sep 3, 2021 ↗ no reply letter on EDGAR (the company may have answered in an amended filing)
Cover Page
SEC asked (1)
Please disclose prominently on the prospectus cover page that you are not a Chinese operating company but a Cayman Islands holding company with operations conducted by your subsidiaries based in Hong Kong and China and that this structure involves unique risks to investors. Provide a cross-reference to your detailed discussion of risks facing the company and the offering as a result of this structure.
CRDO answered

No reply letter found.

Cover Page
SEC asked (2)
Provide prominent disclosure about the legal and operational risks associated with being based in or having the majority of the company’s operations in Hong Kong and China. Your disclosure should make clear whether these risks could result in a material change in your operations and/or the value of your ordinary shares or could significantly limit or completely hinder your ability to offer or continue to offer
Rest of the question

securities to investors and cause the value of such securities to significantly decline or be worthless. Your disclosure should address how recent statements and regulatory actions by China’s government, such as those related to the use of variable interest entities and data security or anti-monopoly concerns, has or may impact the company’s ability to conduct its business, accept foreign investments, or list on an U.S. or other foreign exchange. Your prospectus summary should address, but not necessarily be limited to, the risks highlighted on the prospectus cover page.

CRDO answered

No reply letter found.

Cover Page
SEC asked (3)
Clearly disclose how you will refer to the holding company, subsidiaries, and other entities when providing the disclosure throughout the document so that it is clear to investors which entity the disclosure is referencing and which subsidiaries or entities are conducting the business operations. Refrain from using terms such as “we” or “our” when describing activities or functions of a subsidiary or other entities.
Rest of the question

Disclose clearly the entity (including the domicile) in which investors are purchasing their interest. Prospectus Summary, page 1

CRDO answered

No reply letter found.

Cover Page
SEC asked (4)
In your summary of risk factors, disclose the risks that your corporate structure and being based in or having the majority of the company’s operations in Hong Kong and China poses to investors. In particular, describe the significant regulatory, liquidity, and enforcement risks with cross-references to the more detailed discussion of these risks in the prospectus.
Rest of the question

For example, specifically discuss risks arising from the legal system in China, including risks and uncertainties regarding the enforcement of laws and that rules and regulations in China can change quickly with little advance notice; and the risk that the Chinese government may intervene or influence your operations at any time, or may exert more control over offerings conducted overseas and/or foreign investment in Chinabased issuers, which could result in a material change in your operations and/or the value of your ordinary shares. Acknowledge any risks that any actions by the Chinese government to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers could significantly limit or completely hinder your ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless.

CRDO answered

No reply letter found.

Cover Page
SEC asked (5)
Disclose each permission that you or your subsidiaries are required to obtain from Chinese authorities to operate and issue these securities to foreign investors. State whether you or your subsidiaries are covered by permissions requirements from the China Securities Regulatory Commission (CSRC), the Cyberspace Administration of China (CAC), or any other entity that is required to approve your or your subsidiaries'
Rest of the question

operations, and state affirmatively whether you have received all requisite permissions and whether any permissions have been denied.

CRDO answered

No reply letter found.

Cover Page
SEC asked (6)
Provide a clear description of how cash is transferred through your organization. Disclose your intentions to distribute earnings or settle amounts owed under your operating structure. Quantify any cash flows and transfers of other assets by type that have occurred between the holding company and its subsidiaries and direction of transfer.
Rest of the question

Quantify any dividends or distributions that a subsidiary has made to the holding company and which entity made such transfer, and their tax consequences. Similarly quantify dividends or distributions made to U.S. investors, the source, and their tax consequences. Describe any restrictions on foreign exchange and your ability to transfer cash between entities, across borders, and to U.S. investors. Describe any restrictions and limitations on your ability to distribute earnings from your subsidiaries to the parent company and U.S. investors as well as the ability to settle amounts owed.

CRDO answered

No reply letter found.

Risk Factors, page 14
SEC asked (7)
Given the Chinese government’s significant oversight and discretion over the conduct of your business, please revise to separately highlight the risk that the Chinese government may intervene or influence your operations at any time, which could result in a material change in your operations and/or the value of your common stock.
Rest of the question

Also, given recent statements by the Chinese government indicating an intent to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in Chinabased issuers, acknowledge the risk that any such action could significantly limit or cause the value of such securities to significantly decline or be worthless.

CRDO answered

No reply letter found.

Risk Factors, page 14
SEC asked (8)
In light of recent events indicating greater oversight by the CAC over data security, particularly for companies seeking to list on a foreign exchange, please revise your disclosure to explain how this oversight impacts your business and your offering and to what extent you believe that you are compliant with the regulations or policies that have been issued by the CAC to date.
CRDO answered

No reply letter found.

Business, page 80
SEC asked (9)
The description of your business is highly technical and may be difficult for investors who are not experts in your industry to understand. Please revise your disclosure here and in the Prospectus Summary to ensure it is clear, concise, and understandable in accordance with Rule 421 of Regulation C, including the following: • Eliminate or limit business and technical jargon; explain remaining terms and phrases which
Rest of the question

are technical in nature or whose meaning is not readily apparent; • Reduce your use of acronyms; if there are some acronyms you cannot eliminate, consider using a shortened name for the description instead of an acronym; and • Consider adding pictures, graphs, or other design elements to depict your technology.

CRDO answered

No reply letter found.

Business, page 80
SEC asked (10)
We note contingent language on page 35 that states "to the extent" your products are subject to regulation, their export "may be limited", "may require export authorizations", or may be subject to sale/supply prohibitions. Please revise to clarify the actual need for government approval and effects of governmental regulations on your business. See Item 101(h) of Regulation S-K.
Rest of the question

Please include further information regarding your voluntary self-disclosure concerning apparent export violations, describing the process, potential outcomes, and any material risks that may arise.

CRDO answered

No reply letter found.

Certain Relationships and Related Party Transactions, page 102
SEC asked (11)
We note the amended and restated members agreement provides certain holders pro rata participation rights in sales by you of new securities and information rights. Please clarify whether these participation rights apply to shares being sold in your initial offering and, if so, provide additional information regarding such rights here or in the Underwriting section.
Rest of the question

Please also clarify what is meant by the reference to "information rights." Principal Shareholders, page 105

CRDO answered

No reply letter found.

Certain Relationships and Related Party Transactions, page 102
SEC asked (12)
We note that the information in the beneficial ownership table is current as of April 30, 2021. Please update the information as of the most recent practicable date. See Item 403 of Regulation S-K.
CRDO answered

No reply letter found.

Part II · Item 15. Recent Sales of Unregistered Securities, page II-2
SEC asked (13)
We note the issuance and sale of your convertible preferred shares to recipients who had "adequate access, through their relationships with us, to information about us." Please name the persons or identify the class of persons to whom such securities were sold. See Item 701 of Regulation S-K.
CRDO answered

No reply letter found.

Item 16. Exhibit Index, page II-4
SEC asked (14)
We note references to Proprietary or Confidential Information and Inventions Agreements signed with your named executive officers. Please file a form of such agreement as an exhibit pursuant to Item 601(b)(10). In addition, please revise the footnote to Exhibit 10.9 to indicate that information has been redacted in accordance with Item 601(b)(10)(iv) of Regulation S-K.
CRDO answered

No reply letter found.

Signatures, page II-5
SEC asked (15)
Please confirm that William Brennan, the signatory on behalf of the registrant, is the registrant's duly authorized representative in the United States. See Securities Act Section 6(a) and Instruction 1 under Signatures on Form S-1.
CRDO answered

No reply letter found.

General
SEC asked (16)
Please revise the prospectus cover page to identify the nature of the underwriting arrangements. See Item 501(b)(8) of Regulation S-K. We note that the initial public offering price will be determined through negotiations with the underwriters; please also describe the factors considered in determining the offering price. See Item 505 of
CRDO answered

No reply letter found.

SEC letter of Oct 8, 2021 ↗ no reply letter on EDGAR (the company may have answered in an amended filing)
Prospectus Summary · Risk Factors, page 5
SEC asked (1)
We note your responses and reissue comments 4 and 7 in part. In your summary risk factors, please describe the risk that the Chinese government may intervene or influence your operations at any time, or may exert more oversight and control over offerings conducted overseas, which could result in a material change in your operations and/or the value of your ordinary shares, with cross-references to the more detailed
Rest of the question

discussion of these risks in the prospectus. In your risk factors, given recent statements by the Chinese government indicating an intent to exert more oversight and control over offerings that are conducted overseas, acknowledge the risk that any such action could significantly limit or completely hinder your ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless.

CRDO answered

No reply letter found.

Prospectus Summary · Risk Factors, page 5
SEC asked (2)
We note your response and reissue comment 5 in part. Disclose each permission that you are required to obtain from Chinese authorities to issue these securities to foreign investors; if none, please affirmatively so state and describe any associated risks to investors. Please revise your disclosure relating to permissions to operate business in China on page 97 to also refer to your subsidiaries in Hong Kong.
CRDO answered

No reply letter found.

Holding Company Structure and PRC Operations, page 6
SEC asked (3)
We note that your definition of "China" and "PRC" excludes Hong Kong, Macau, and Taiwan. Please revise your disclosure throughout the prospectus to include references to Hong Kong as appropriate, for example in statements such as the following: "We have not relied on dividends and other distributions on equity from our PRC subsidiaries for our cash requirements, as we have generated a limited amount of revenue in
Rest of the question

China to date."

CRDO answered

No reply letter found.

Holding Company Structure and PRC Operations, page 6
SEC asked (4)
We note your disclosure that more than 75% of your assets were held by entities located in the United States and Cayman Islands, and less than 25% of your assets were held by entities located in Hong Kong and China. By contrast, Note 13 of your financial statements indicates that nearly 60% of your long-lived assets are located in Taiwan.
Rest of the question

Please revise your disclosure to clarify how your assets located in Taiwan are reflected.

CRDO answered

No reply letter found.

Holding Company Structure and PRC Operations, page 6
SEC asked (5)
We note your response to prior comment 6 and reissue it in part. Our comment requests a clear description of how cash is transferred through your organization, while your disclosure appears to solely reference dividends and distributions from your subsidiaries in China.
Rest of the question

Please supplement your disclosure to reflect any other cash transfers, with these or other subsidiaries, or alternatively confirm that no such transfers exist. Disclose your intentions to distribute earnings or settle amounts owed under your operating structure. Quantify any cash flows and transfers of other assets by type that have occurred between the holding company and its subsidiaries and direction of transfer. Quantify any dividends or distributions that a subsidiary has made to the holding company and which entity made such transfer, and their tax consequences. Similarly quantify dividends or distributions made to U.S. investors, the source, and their tax consequences. Describe any restrictions on foreign exchange and your ability to transfer cash between entities, across borders, and to U.S. investors. Describe any restrictions and limitations on your ability to distribute earnings from your subsidiaries to the parent company and U.S. investors as well as the ability to settle amounts owed.

CRDO answered

No reply letter found.

General
SEC asked (6)
Please supplementally provide us with copies of all written communications, as defined in Rule 405 under the Securities Act, that you, or anyone authorized to do so on your behalf, present to potential investors in reliance on Section 5(d) of the Securities Act, whether or not they retain copies of the communications.
Rest of the question

Please contact the staff member associated with the review of this filing to discuss how to submit the materials, if any, to us for review.

CRDO answered

No reply letter found.

SEC letter of Oct 27, 2021 ↗ no reply letter on EDGAR (the company may have answered in an amended filing)
Cover Page
SEC asked (1)
Please expand your disclosure on the prospectus cover page to provide a description of how cash is transferred through your organization. State whether any transfers, dividends, or distributions have been made to date.
CRDO answered

No reply letter found.

Prospectus Summary · Our Competitive Strengths, page 3
SEC asked (2)
Please revise the sentence, "We are engaged with five of the top seven hyperscalers . . . ," to clarify the nature of these relationships; i.e., whether they are legally enforceable contractual relationships or less formal working arrangements. Please clearly describe each party's respective rights and obligations, if material.
Rest of the question

Please make conforming changes to the reference to "our more than 20 IP engagements" on page 104.

CRDO answered

No reply letter found.

Risk Factors & Recent Regulatory Developments, page 5
SEC asked (3)
We note your response to prior comment 1. Please further revise your prospectus summary and related risk factors to acknowledge that the risks described could cause the value of your securities to significantly decline or become worthless and could significantly limit or completely hinder your ability to offer or continue to offer securities to investors.
Rest of the question

If you disagree with this disclosure, please provide your analysis.

CRDO answered

No reply letter found.

Holding Company Structure, page 6
SEC asked (4)
We note your response to prior comment 3. Please revise your disclosure to indicate (by parenthetical or otherwise) that the long-lived assets located in Taiwan are owned by your Cayman Islands subsidiary in order to resolve the apparent inconsistency between the two statements regarding assets.
CRDO answered

No reply letter found.

General
SEC asked (5)
We have reviewed the investor presentations supplementally provided to us in response to prior comment 6. Please revise your prospectus to disclose the projections related to your financial results that are included within your investor presentations. Please also disclose the material estimates and assumptions underlying these financial projections.
CRDO answered

No reply letter found.

SEC letter of Nov 15, 2021 ↗ no reply letter on EDGAR (the company may have answered in an amended filing)
Prospectus Summary · Risk Factors, page 6
SEC asked (1)
Disclose that trading in your securities may be prohibited under the Holding Foreign Companies Accountable Act if the PCAOB determines that it cannot inspect or fully investigate your auditor, and that as a result an exchange may determine to delist your securities. If the PCAOB has been or is currently unable to inspect your auditor, revise your disclosure to so state.
CRDO answered

No reply letter found.

Recent Regulatory Developments, page 10
SEC asked (2)
Please disclose whether you are required to obtain any approvals to offer securities to foreign investors, whether you have received such approvals, and the consequences to you and your investors if you do not receive and maintain the approvals, inadvertently conclude that such approvals are not required, or applicable laws, regulations, or interpretations change and you are required to obtain approval in the future.
CRDO answered

No reply letter found.

Risk Factors · Risks Related to Our International Operations, page 38
SEC asked (3)
We note from the audit opinion that you have a U.S.-based auditor that is registered with the PCAOB and currently subject to PCAOB inspection. Please disclose any material risks to the company and investors if it is later determined that the PCAOB is unable to inspect or investigate completely your auditor because of a position taken by an authority in a foreign jurisdiction.
Rest of the question

For example, disclose the risk that lack of inspection could cause trading in your securities to be prohibited under the Holding Foreign Companies Accountable Act and as a result an exchange may determine to delist your securities.

CRDO answered

No reply letter found.

Risk Factors · Risks Related to Our International Operations, page 38
SEC asked (4)
Please expand your risk factor disclosure to discuss that the United States Senate passed the Accelerating Holding Foreign Companies Accountable Act, which, if enacted, would decrease the number of non-inspection years from three years to two, thus reducing the time period before your securities may be prohibited from trading or delisted.
CRDO answered

No reply letter found.

SEC asked
Please revise the final sentence of the first paragraph under this caption to remove the words "without restriction."
CRDO answered
In response to the Staff’s comment, the Company has revised the disclosure on page 43 of the Registration Statement.

We hope the foregoing answer is responsive to your comments. Please do not hesitate to contact me at (650) 752-2004 or at [email protected] with any questions or comments regarding this correspondence.
Read in the reply
SEC asked (1)
We note that Exhibit 10.17 contains a reference to an Exhibit E which does not appear in the filing. Please refile your exhibit with the omitted Exhibit E.
CRDO answered
In response to the Staff’s comment, the Company has refiled the warrant listed as Exhibit 10.17 with the Exhibit E to such warrant.
Read in the reply
SEC asked (2)
We note that counsel's opinion as to Sales Shares having been duly authorized, legally issued, fully paid, and non-assessable appears limited by the proviso, "Based solely of our inspection of the Register of Members." Please request counsel to separate or otherwise revise paragraph 3.2 of Exhibit 5.1 so that the foregoing opinion is not thus limited.
CRDO answered
In response to the Staff’s comment, Maples & Calder (Cayman) LLP has revised paragraphs 2.9 and 3.2 of its Exhibit 5.1 legal opinion, which the Company has refiled as an exhibit to the Revised Registration Statement.

We hope the foregoing answers are responsive to your comments. Please do not hesitate to contact me at (650) 752-2004 or at [email protected] with any questions or comments regarding this correspondence.
Read in the reply

Letters without questions

Other letters

UPLOAD and CORRESP
3 other letters: notices that a filing will not be reviewed, requests to declare a registration effective, and the like

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 17 letters filed since 2021-09-03. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CRDO/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.